Fibroblast growth factor-2 mediates transforming growth factor-Β action in prostate cancer reactive stroma

Oncogene

Volumn 27, Issue 4, 2008, Pages 450-459

  Yang, F ^a   Strand, D W ^a   Rowley, D R ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Angiogenesis; Fibroblast growth factor; Prostate cancer; Stroma; Transforming growth factor

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN LNCAP; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR GROWTH; XENOGRAFT;

ANIMALS; CARCINOMA; DISEASE PROGRESSION; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 38349105902     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210663     Document Type: Article

References (37)

1. Akhurst RJ, Derynck R. (2001). TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol 11: S44-S51.
2. Backhaus R, Zehe C, Wegehingel S, Kehlenbach A, Schwappach B, Nickel W. (2004). Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding. J Cell Sci 117: 1727-1736.
3. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S et al. (2004). TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851.
4. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M et al. (2004). Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J Immunol 173: 2099-2108.
5. Butter S, Laping NJ, Pullen M, Grygielko E, Olson B, Brooks DP. (2001). The role of transforming growth factor-beta and its receptors in human prostate smooth muscle cell fibronectin production. Eur J Pharmacol 422: 47-52.
6. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R et al. (2005). Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene 24: 5053-5068.
7. Choy L, Skillington J, Derynck R. (2000). Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol 149: 667-682.
8. Coffey Jr RJ, Shipley GD, Moses HL. (1986). Production of transforming growth factors by human colon cancer lines. Cancer Res 46: 1164-1169.
9. Derynck R, Zhang YE. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584.
10. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G.(1993). Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-111.
11. Dow JK, deVere White RW. (2000). Fibrobla st growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology 55: 800-806.
12. Dvorak HF. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New Engl J Med 315: 1650-1659.
13. Eastham JA, Truong LD, Rogers E, Kattan M, Flanders KC, Scardino PT et al. (1995). Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. Lab Invest 73: 628-635.
14. Fukabori Y, Nakano K, Ohyama A, Yamanaka H. (1997). Stimulative effect of transforming growth factor-beta on collagen synthesis by human prostatic stromal cells in vitro. Int J Urol 4: 597-602.
15. Giri D, Ropiquet F, Ittmann M. (1999). Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer. Clin Cancer Res 5: 1063-1071.
16. Hayashi T, Hideshima T, Nguyen AN, Munoz O, Podar K, Hamasaki M et al. (2004). Transform ing growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment. Clin Cancer Res 10: 7540-7546.
17. Huss WJ, Barrios RJ, Foster BA, Greenberg NM. (2003). Differential expression of specific FGF ligand and receptor isoforms during angiogenesis associated with prostate cancer progression. Prostate 54: 8-16.
18. Igarashi A, Okochi H, Bradham DM, Grotendorst GR. (1993). Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637-645.
19. Lakos G, Takagawa S, Chen SJ, Ferreira AM, Han G, Masuda K et al. (2004). Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol 165: 203-217.
20. Liotta LA, Kohn EC. (2001). The microenvironment of the tumour-host interface. Nature 411: 375-379.
21. Peehl DM, Sellers RG. (1998). Basic FGF, EGF, and PDGF modify TGFbeta-induction of smooth muscle cell phenotype in human prostatic stromal cells. Prostate 35: 125-134.
22. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O et al. (1994). Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269: 6271-6274.
23. Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S et al. (2003). Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer. Cancer Res 63: 5754-5760.
24. Roberts AB, Russo A, Felici A, Flanders KC. (2003). Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann NY Acad Sci 995: 1-10.
25. Roberts AB, Sporn MB. (1996). Transform ing growth factor-β. In: Clark RAF (ed). The Molecular and Cellular Biology of Wound Repair. Plenum Press: New York, NY, pp 275-308.
26. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM et al. (1986). Transform ing growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167-4171.
27. Ronnov-Jessen L, Petersen OW, Bissell MJ. (1996). Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 76: 69-125.
28. Rowley DR.(2007). Reactive stroma and evolution of tumors: integration of transforming growth factor-beta, connective tissue growth factor, and fibroblast growth factor-2 activities. In: Jakowlew S (ed). Transforming Growth Factor-Beta in Cancer Therapy. Humana Press: Towta.
29. Sakko AJ, Ricciardelli C, Mayne K, Tilley WD, Lebaron RG, Horsfall DJ. (2001). Versican accumulation in human prostatic fibroblast cultures is enhanced by prostate cancer cell-derived transforming growth factor beta1. Cancer Res 61: 926-930.
30. Silver DP, Livingston DM. (2001). Self-excising retroviral vectors encoding the Cre recombinase overcome Cre-mediated cellular toxicity. Mol Cell 8: 233-243.
31. Story MT, Hopp KA, Meier DA. (1996). Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells. Prostate 28: 219-226.
32. Tuxhorn JA, Ayala GE, Rowley DR. (2001). Reactive stroma in prostate cancer progression. J Urol 166: 2472-2483.
33. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. (2002a). Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 8: 2912-2923.
34. Tuxhorn JA, McAlhany SJ, Dang TD, Ayala GE, Rowley DR. (2002b). Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res 62: 3298-3307.
35. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR. (2002c). Inhibition of TGF-β activity decreases angiogenesis in a human prostate cancer reactive stroma xenograft model. Cancer Res 62: 6021-6025.
36. Uchiyama-Tanaka Y, Matsubara H, Mori Y, Kosaki A, Kishimoto N, Amano K et al. (2002). Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. Kidney Int 62: 799-808.
37. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. (2005). Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895.